Pulmonx Corporation (LUNG)
NASDAQ: LUNG · IEX Real-Time Price · USD
7.79
-0.13 (-1.64%)
Jul 22, 2024, 10:07 AM EDT - Market open
Pulmonx Employees
Pulmonx had 279 employees as of December 31, 2023. The number of employees increased by 10 or 3.72% compared to the previous year.
Employees
279
Change (1Y)
10
Growth (1Y)
3.72%
Revenue / Employee
$261,627
Profits / Employee
-$210,509
Market Cap
309.36M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 279 | 10 | 3.72% |
Dec 31, 2022 | 269 | 16 | 6.32% |
Dec 31, 2021 | 253 | 33 | 15.00% |
Dec 31, 2020 | 220 | 40 | 22.22% |
Dec 31, 2019 | 180 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Aurora Cannabis | 1,073 |
OraSure Technologies | 638 |
SOPHiA GENETICS | 430 |
MacroGenics | 339 |
Sutro Biopharma | 302 |
Nyxoah | 147 |
Enanta Pharmaceuticals | 145 |
Atea Pharmaceuticals | 75 |
LUNG News
- 11 days ago - Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024 - GlobeNewsWire
- 2 months ago - Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Pulmonx Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024 - GlobeNewsWire
- 3 months ago - Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer - GlobeNewsWire
- 5 months ago - Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial - Business Wire
- 5 months ago - Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 5 months ago - Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer - GlobeNewsWire